Research analysts who have asked questions during BRASKEM earnings calls.
Gabriel Coelho Barra
Citigroup
5 questions for BAK
Luiz Carvalho
UBS
5 questions for BAK
Rodrigo Reis de Almeida
Santander
5 questions for BAK
Anne Milne
Bank of America Merrill Lynch
3 questions for BAK
Enrique Duong
BTG Pactual
3 questions for BAK
Leonardo Marcondes
Bank of America
3 questions for BAK
Regis Cardoso
XP Investimentos
3 questions for BAK
Vicente Falanga Neto
Bradesco BBI
3 questions for BAK
Henrique Perez
BTG Pactual
2 questions for BAK
Nicolas Barros
Itau BBA
2 questions for BAK
Pedro Gama
Citigroup Inc.
2 questions for BAK
Tasso Vasconcellos
UBS Group AG
2 questions for BAK
Till Lois
Schroders
2 questions for BAK
Bruno Montanari
Morgan Stanley
1 question for BAK
Gabriel Baja
Citigroup
1 question for BAK
Tasovas Gonzalez
UBS
1 question for BAK
Recent press releases and 8-K filings for BAK.
- Braskem S.A. reported that its subsidiary, Braskem Idesa S.A.P.I., is engaged in discussions with holders of its 7.450% Senior Secured Notes due 2029 and 6.990% Senior Secured Notes due 2032 regarding a possible reorganization of its capital structure.
- Confidentiality agreements were entered into on December 18, 2025, to facilitate the sharing of non-public information with investors.
- Braskem Idesa and the investors exchanged proposals for the restructuring, including an "Investor Proposal" dated January 6, 2026, but no agreement has been reached between the parties.
- Braskem Idesa has indicated that it will not agree to the terms proposed in the Investor Proposal.
- Fitch Ratings has revised BRASKEM S.A.'s global corporate credit rating to CC.
- This revision occurred on December 30, 2025, and is attributed to a prolonged global downturn in the petrochemical industry.
- BRASKEM S.A. is focused on implementing resilience and transformation initiatives to mitigate these significant effects and strengthen its competitiveness.
- Braskem S.A. has signed long-term purchase and sale agreements with Petr\u00f3leo Brasileiro S.A. \u2013 Petrobras for essential petrochemical raw materials, with contracts commencing from early 2026.
- These agreements include a 5-year Petrochemical Naphtha contract, starting January 1, 2026, for quantities reaching up to 4.116 million tons in 2026 and 4.316 million tons in 2030.
- An 11-year Ethane, Propane, and Hydrogen contract, also effective January 1, 2026, will increase contracted quantities to 725 thousand tons of ethylene equivalent per year from 2029 to 2036 to support production capacity expansion in Rio de Janeiro.
- Additionally, 5-year Propylene Purchase and Sale Contracts will begin on May 18, 2026, securing up to 140 thousand tons per year at Recap and 100 thousand tons at Reduc.
- BRASKEM S.A. was informed on December 15, 2025, that Shine I Fundo de Investimento em Direitos Creditórios de Responsabilidade Limitada (FIDC) entered into a definitive binding agreement with creditor banks of NSP Investimentos S.A. to acquire credits guaranteed by Braskem shares.
- FIDC and Novonor S.A. (parent company of NSP Investimentos S.A.) have also signed a sixty (60) day exclusivity agreement to negotiate a potential transaction involving Braskem shares held by NSP Investimentos S.A..
- Upon completion of this potential transaction, an investment fund advised by IG4 Sol. Ltda. or its affiliate is expected to hold 50.111% of Braskem's voting capital and 34.323% of its total capital, while the Novonor group would retain four percent (4%) of Braskem's total capital in preferred shares.
- BRASKEM S.A. (BAK) stated on December 3, 2025, that it is not aware of information contained in media reports regarding a sale process and is not conducting any negotiations for the sale of the company.
- Shareholder Novonor S.A. informed that negotiations are underway with IG4 Solutions LLC to establish an exclusivity commitment regarding Braskem shares, though no binding document has been signed and there is no guarantee of an agreement.
- Petrobras, another shareholder, clarified it is not a party to the agreement between Novonor and IG4 and has not made a decision regarding its stake in Braskem, continuing to study alternatives.
- Braskem S.A. held an Extraordinary General Meeting on November 13, 2025, to vote on key corporate matters.
- Shareholders approved the replacement of one effective member of the Company’s Board of Directors appointed by Novonor S.A. and NSP Investimentos S.A..
- The resolution for the Board member replacement received substantial approval, including 212,426,952 common shares and 75,761,739 preferred shares from one major shareholder, and 226,334,622 common shares and 79,182,486 preferred shares from another.
- The meeting also resulted in the approval of the consolidation of the Company's Bylaws.
- BRASKEM S.A. held an Extraordinary General Meeting (EGM) on November 13, 2025, with high shareholder participation, including 97.91% of common shares and 75.77% of preferred shares.
- Shareholders approved the replacement of one effective member of the Company's Board of Directors and the new composition of the Board.
- Key amendments to the Company's Bylaws were approved, including an update to the corporate purpose (Article 2) to align with current activities and the inclusion of detailed rules for the election of the Board of Directors (new Article 20) to enhance transparency.
- The Bylaws were also amended to update the Board of Directors' approval thresholds and grant the Board authority to annually adjust these thresholds, while removing its responsibility for selecting independent auditors of subsidiaries (Article 26).
- BRASKEM S.A. reported Recurring EBITDA of US$150 million for Q3 2025, representing a 104% increase compared to Q2 2025, though a 65% decrease from Q3 2024.
- The company's cash position was approximately US$1.3 billion, with total liquidity around US$2.3 billion (including a stand-by facility), providing coverage for debt maturities for approximately 27 months.
- The petrochemical industry is projected to experience a prolonged downcycle extending until the end of the decade, with only a modest recovery expected after 2029.
- BRASKEM is advancing its Resilience and Transformation Program, which aims to capture approximately US$400 million in EBITDA and US$500 million in cash.
- The Rio de Janeiro Complex expansion was approved in October 2025, set to increase ethylene capacity by 220 kton/year with an estimated investment of ~R$4.2 billion and completion by the end of 2028.
- BRASKEM S.A. reported consolidated recurring EBITDA of US$150 million (R$818 million) in Q3 2025, representing a 104% increase compared to Q2 2025, but recorded a net loss attributable to shareholders of US$1 million (R$26 million) for the quarter.
- Segment performance was mixed, with Brazil/South America's recurring EBITDA increasing 35% to US$205 million, while the United States and Europe, and Mexico segments reported negative recurring EBITDAs of US$15 million and US$37 million, respectively.
- The company's corporate gross debt stood at approximately US$8.4 billion at the end of Q3 2025, with a cash position of US$1.3 billion (excluding Braskem Idesa).
- An agreement was reached with the State of Alagoas on November 10, 2025, for a total payment of R$1.2 billion related to the geological event, with the provision balance for this event at R$3.8 billion at the end of Q3 2025.
- Total expected investments for 2025 are US$404 million (R$2.4 billion), with US$133 million (R$725 million) invested in Q3 2025.
- Braskem S.A. reported a net loss of R$174 million for Q3 2025 on net revenue of R$17,299 million. For the nine-month period ended September 30, 2025, the company recorded a net profit of R$68 million and basic common earnings per share of R$0.4336.
- The company experienced a decrease in cash and cash equivalents of R$8,323 million for the nine-month period ended September 30, 2025, with net cash used in operating activities totaling R$3,300 million. Total assets decreased to R$87,383 million as of September 30, 2025, from R$101,575 million at year-end 2024.
- Braskem is pursuing capacity expansion projects and inaugurated the Terminal Química Puerto México in May 2025. An industrial transformation in Alagoas, involving the mothballing of chlorine and caustic soda production, resulted in R$784 million in impairment losses and provisions in September 2025.
- The provision for the geological event in Alagoas decreased to R$3,784 million as of September 30, 2025, from R$5,570 million at year-end 2024, following an agreement with the State of Alagoas for R$1.2 billion on November 10, 2025. Additionally, provisional anti-dumping duties on PE imports from the US and Canada were approved in August 2025, and a 20% import tax for PE, PP, and PVC resins was maintained until October 2026.
Quarterly earnings call transcripts for BRASKEM.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more